Astera Labs (NASDAQ:ALAB) Stock Price Down 6.2% - Here's What Happened

Key Points

• Astera Labs shares fell 6.2% to about $284.64 in mid-day trading, with volume roughly 89% below the average session level.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $333, although recent targets have ranged widely from $153 to $460.
• The company recently exceeded quarterly expectations, reporting $0.80 in earnings per share and $392.4 million in revenue, up 104.5% year over year. Insiders have sold approximately $215.5 million worth of shares over the past 90 days.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price traded down 6.2% during mid-day trading on Wednesday . The company traded as low as $288.00 and last traded at $284.6360. 606,922 shares changed hands during trading, a decline of 89% from the average session volume of 5,464,001 shares. The stock had previously closed at $303.44.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Rothschild & Co Redburn began coverage on Astera Labs in a research note on Friday, May 1st. They set a "neutral" rating and a $153.00 target price on the stock. Weiss Ratings raised Astera Labs from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, May 21st. TD Cowen lowered their price target on Astera Labs from $425.00 to $375.00 and set a "hold" rating on the stock in a report on Wednesday, August 5th. Stifel Nicolaus lifted their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the company a "buy" rating in a research note on Wednesday, June 24th. Finally, Roth Capital reaffirmed a "buy" rating and issued a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $333.00.

Astera Labs Price Performance

The business has a fifty day moving average of $356.72 and a 200-day moving average of $242.75. The stock has a market capitalization of $49.35 billion, a price-to-earnings ratio of 141.11 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same period in the prior year, the company earned $0.44 EPS. Astera Labs's revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insider Buying and Selling

In other news, Director Jack R. Lazar sold 10,000 shares of the company's stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the sale, the director directly owned 75,688 shares of the company's stock, valued at $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the company's stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total transaction of $270,997.44. Following the sale, the director directly owned 5,550 shares of the company's stock, valued at $2,192,472. This represents a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 631,979 shares of company stock valued at $215,479,247 over the last ninety days. 10.40% of the stock is currently owned by company insiders.

Institutional Trading of Astera Labs

Institutional investors have recently bought and sold shares of the company. Glenmede Trust Co. NA lifted its position in shares of Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company's stock worth $209,000 after acquiring an additional 51 shares during the period. Keating Financial Advisory Services Inc. acquired a new position in shares of Astera Labs in the second quarter valued at $25,000. Lido Advisors LLC raised its stake in shares of Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company's stock valued at $2,046,000 after purchasing an additional 57 shares in the last quarter. Archer Investment Corp bought a new position in Astera Labs in the second quarter worth $30,000. Finally, Transamerica Financial Advisors LLC bought a new position in Astera Labs in the second quarter worth $35,000. Institutional investors and hedge funds own 60.47% of the company's stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source